SCHEMBL574908

SCHEMBL574908

COC(=O)c1cc(N)c(Oc2ccc(F)cc2)c(S(=O)(=O)/N=C/N(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.39
HPGD P15428 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
USP2 O75604 1/20 0.37
GAA P10253 2/20 0.35
PKM P14618 1/20 0.35
ACLY P53396 1/20 0.34
RAB9A P51151 2/20 0.34
KMT2A Q03164 2/20 0.33
GLA P06280 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
ATM Q13315 1/20 0.33
HSD17B10 Q99714 1/20 0.33
IKBKB O14920 1/20 0.33
CMA1 P23946 1/20 0.33
BRAF P15056 1/20 0.33
HDAC1 Q13547 1/20 0.33
STS P08842 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574909 1.00 KDM4E (0.39) KDM4EHPGDALDH1A1MAPTUSP2
SCHEMBL10224539 1.00 KDM4E (0.39) KDM4EHPGDALDH1A1MAPTUSP2
SCHEMBL11004645 0.92 CA1 (0.38) KDM4EHPGDALDH1A1MAPTUSP2
SCHEMBL10998937 0.91 GAA (0.41) KDM4EHPGDALDH1A1MAPTUSP2
SCHEMBL11512665 0.90 ALDH1A1 (0.39) KDM4EHPGDALDH1A1MAPTUSP2
SCHEMBL573731 0.90 HPGD (0.43) KDM4EHPGDALDH1A1MAPTUSP2
SCHEMBL574175 0.90 HPGD (0.43) KDM4EHPGDALDH1A1MAPTUSP2
SCHEMBL10222901 0.90 HPGD (0.43) KDM4EHPGDALDH1A1MAPTUSP2
SCHEMBL11510955 0.85 ALDH1A1 (0.36) KDM4EHPGDALDH1A1MAPTUSP2
SCHEMBL11512629 0.85 LNPEP (0.45) KDM4EHPGDALDH1A1GAAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed